Cartesian Therapeutics reports Q3 2026 financial results
Cartesian Therapeutics, Inc. releases its Q3 2026 financial results, providing insights into its performance and future outlook in the pharmaceutical industry.
Avalo Therapeutics reports Q3 results, highlights challenges
Avalo Therapeutics, Inc. shares Q3 results, revealing key financial developments and challenges in the pharmaceutical preparations industry.
Amylyx Pharmaceuticals Releases Q3 2026 Financial Results
Amylyx Pharmaceuticals announces its Q3 2026 financial results, highlighting progress in its pharmaceutical pipeline amid industry competition.
Evolent Health reports Q3 results with rising revenue
Evolent Health, Inc. shows revenue growth and reduced losses in Q3, impacting the management services sector and setting a benchmark for competitors.
HSBC announces redemption of senior unsecured notes
HSBC Holdings PLC reveals plans to redeem $1.27 billion in senior unsecured notes, impacting its financial structure and the savings institution sector.
Real REMAX Group Inc. Reports Third Quarter Results
Real REMAX Group Inc. releases its Q3 2026 results, highlighting performance metrics that could impact its operations and competitive stance in real estate.
Horizon Quantum Plans $27 Million Acquisition of Entropica Labs
Horizon Quantum Holdings Ltd. announces a $27 million acquisition of Entropica Labs to strengthen its quantum software capabilities.
Shutterstock Reports Q3 Results, Highlights Growth Strategies
Shutterstock, Inc. announces its Q3 financial results, revealing insights into revenue and operational efficiency as of September 30, 2026.
C4 Therapeutics reports Q3 results, highlights cemsidomide trials
C4 Therapeutics announces third-quarter results, emphasizing progress in cemsidomide clinical trials and upcoming milestones for 2027.
Shutterstock appoints Interim CFO amid Q3 financial results
Shutterstock, Inc. announces Scott Grossman as Interim CFO following Rik Powell's departure, alongside significant Q3 financial results showing a net loss.
Aclaris Therapeutics Reports Q3 2026 Financial Results
Aclaris Therapeutics, Inc. announces its financial results for Q3 2026, highlighting ongoing developments in the pharmaceutical sector.
Verisk Analytics reports Q3 2026 results amid challenges
Verisk Analytics, Inc. announces Q3 2026 financial results, showing revenue growth but a decline in net income, reflecting industry challenges.
Lincoln International Reports Record Q3 2026 Financial Results
Lincoln International, Inc. announces record revenues and earnings for Q3 2026, showcasing strong growth in investment banking and valuation services.
TIC Solutions Reports Record Revenue in Third Quarter Results
TIC Solutions, Inc. announces record third-quarter revenue of $639.6 million, marking a 35% increase year-over-year despite a net loss.
Fate Therapeutics reports Q3 2026 results, updates pipeline
Fate Therapeutics Inc. reports its Q3 2026 results, highlighting advancements in its product pipeline and financial position amid a competitive biotech landscape.
Zenas BioPharma Reports Third Quarter 2026 Financial Results
Zenas BioPharma announces third-quarter results, emphasizing progress in drug development and preparations for obexelimab's potential commercialization.
Certara Reports Q3 2026 Results, Appoints New Chief Product Officer
Certara, Inc. announces Q3 2026 financial results with significant software revenue growth and the appointment of a new Chief Product Officer.
Cooper-Standard reports Q3 results amid financial challenges
Cooper-Standard Holdings Inc. posts mixed Q3 results with a net loss but strong new business awards, facing inflation and production challenges.
Climb Bio reports Q3 2026 results, updates corporate presentation
Climb Bio, Inc. announces its Q3 2026 financial results and updates its corporate presentation, highlighting its position in the pharmaceutical preparations sector.
REGENXBIO reports Q3 2026 financial results amid challenges
REGENXBIO Inc. announces its financial results for Q3 2026, showcasing ongoing challenges in the biological products sector.